Centre selected in third round of last year’s NHL Draft looking to make a name for himself after father left his mark in ...

Citius is also developing the drug for peripheral T-cell lymphoma indication (PTCL) and immuno-oncology indications, which Citius reckons both have larger sales potential than CTCL if approved.

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated diffuse large B-cell lymphoma (DLBCL), cementing the antibody-drug conjugate ...

Lymphoma is a type of cancer that begins in immune system cells, called lymphocytes. It generally presents as a solid tumor of lymphoid cells and can develop in the lymph nodes, spleen, bone ...